Cargando…
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis
BACKGROUND: Sporothrix brasiliensis is the most virulent sporotrichosis agent. This species usually responds to antifungal drugs, but therapeutic failure can occur in some patients. Antifungal susceptibility tests have been performed on this species, but no clinical breakpoints (CBPs) are available....
Autores principales: | Almeida-Paes, Rodrigo, Brito-Santos, Fábio, Figueiredo-Carvalho, Maria Helena Galdino, Machado, Ana Caroline Sá, Oliveira, Manoel Marques Evangelista, Pereira, Sandro Antonio, Gutierrez-Galhardo, Maria Clara, Zancopé-Oliveira, Rosely Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398167/ https://www.ncbi.nlm.nih.gov/pubmed/28443986 http://dx.doi.org/10.1590/0074-02760160527 |
Ejemplares similares
-
Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine
por: Almeida-Paes, Rodrigo, et al.
Publicado: (2016) -
Severe Sporotrichosis Caused by Sporothrix brasiliensis: Antifungal Susceptibility and Clinical Outcomes
por: Fichman, Vivian, et al.
Publicado: (2022) -
Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis Is Associated with Atypical Clinical Presentations
por: Almeida-Paes, Rodrigo, et al.
Publicado: (2014) -
Sporothrix brasiliensis and Feline Sporotrichosis in the Metropolitan Region of Rio de Janeiro, Brazil (1998–2018)
por: Boechat, Jéssica Sepulveda, et al.
Publicado: (2022) -
Sporotrichosis Caused by Non-Wild Type Sporothrix brasiliensis Strains
por: Bernardes-Engemann, Andréa Reis, et al.
Publicado: (2022)